Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q4 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $6.34 million versus the consensus estimate of $6.15 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2024 revenue of at least $27 million, versus the consensus of $28.121 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.